Reaction Details
Report a problem with these data
Report a problem with these dataTarget
Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D]
Ligand
BDBM337260
Substrate
n/a
Meas. Tech.
Kinase High ATP Assay
IC50
44.0±n/a nM
Citation
Zorn, L; Eis, K; Schulze, V; Sülzle, D; Puehler, F; Lienau, P; Bömer, U; Petersen, K; Hägebarth, A Amidoimidazopyridazines as MKNK-1 kinase inhibitors US Patent US9745304 Publication Date 8/29/2017 More Info.:
Target
Name:
Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D]
Synonyms:
Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] | Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) [T344D] | MAP kinase signal-integrating kinase 1 (MNK1) (T344D) | MAP kinase-interacting serine/threonine-protein kinase 1 (MKNK1) | MAP kinase-interacting serine/threonine-protein kinase 1 (MKNK1) (T344D) | MAP kinase-interacting serine/threonine-protein kinase 1 (MKNK1)(T344D) | MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) [T344D] | MAP kinase-interacting serine/threonine-protein kinase 1 (T344D) | MKNK1 | MKNK1 (aa 1-424) T344D | MKNK1_HUMAN | MNK1 | MNK1a
Type:
Protein
Mol. Mass.:
47416.00
Organism:
Homo sapiens (Human)
Description:
Q9BUB5-2 with T344D
Residue:
424
Sequence:
MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL
Inhibitor
Name:
BDBM337260
Synonyms:
N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(4-fluorophenyl)propanamide | US9745304, Example 29
Type:
Small organic molecule
Emp. Form.:
C23H17FN4O2
Mol. Mass.:
400.4051
SMILES:
Fc1ccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cc1
Structure:
